233 related articles for article (PubMed ID: 2547241)
1. [Cutaneous leishmaniasis].
Vion B
Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
[No Abstract] [Full Text] [Related]
2. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
[No Abstract] [Full Text] [Related]
3. [Treatment of localized cutaneous leishmaniasis].
Buffet P; Caumes E; Gentilini M
Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
[No Abstract] [Full Text] [Related]
4. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
Costa JM; Vale KC; França F; Lago EL; Magalhães AV; Marsden PD; Sampaio RN
Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
[No Abstract] [Full Text] [Related]
5. New delivery strategies for the old pentavalent antimonial drugs.
Frézard F; Demicheli C
Expert Opin Drug Deliv; 2010 Dec; 7(12):1343-58. PubMed ID: 21029028
[TBL] [Abstract][Full Text] [Related]
6. Treatment of kala-azar in India.
Thakur CP
Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
[No Abstract] [Full Text] [Related]
7. Leishmaniasis.
Evans TG
Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapy of protozoal infections: whither?
Steck EA
J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
[No Abstract] [Full Text] [Related]
9. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
[TBL] [Abstract][Full Text] [Related]
10. Leishmaniasis recidivans treated with sodium stibogluconate.
Schewach-Millet M; Fisher BK; Semah D
Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Chulay JD; Fleckenstein L; Smith DH
Trans R Soc Trop Med Hyg; 1988; 82(1):69-72. PubMed ID: 2845611
[TBL] [Abstract][Full Text] [Related]
12. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC
J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of leishmaniasis in India.
Thakur CP
Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
[No Abstract] [Full Text] [Related]
14. Emergency initiative to reduce leishmaniasis in Afghanistan.
Querido J
Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
[No Abstract] [Full Text] [Related]
15. Diffuse cutaneous leishmaniasis acquired in Peru.
Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS
Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221
[TBL] [Abstract][Full Text] [Related]
16. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
Soto J; Toledo J; Vega J; Berman J
Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of visceral leishmaniasis.
Davidson RN; Croft SL
Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
[No Abstract] [Full Text] [Related]
18. Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
Wkly Epidemiol Rec; 2017 Sep; 92(35):566-72. PubMed ID: 28945058
[No Abstract] [Full Text] [Related]
19. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
[No Abstract] [Full Text] [Related]
20. Interferon gamma therapy for cutaneous leishmaniasis.
Kürkçüoğlu N; Tandoğdu R
Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
[No Abstract] [Full Text] [Related]
[Next] [New Search]